IGMS

IGM Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

IGMS price

IGM Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IGMS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IGMS

Valuation

P/E

Sector -3.50

Industry -3.50

P/BV

Sector 2.01

Industry 2.01

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-0.81

Sector -223.67

Industry -223.67

EV/EBIT

-0.81

Sector -47.92

Industry -47.92

P/EBITDA

Sector -21.50

Industry -21.50

P/EBIT

Sector -28.21

Industry -28.21

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

0.00

Sector -10.26

Industry -10.26

P/Working Capital

0.00

Sector -167.98

Industry -167.98

EPS

Sector -1.79

Industry -1.79

BVPS

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

Sector 41.30%

Industry 41.30%

EBITDA Margin

89.56%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

89.25%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

Sector -35.21%

Industry -35.21%

Net Profit Margins

Sector -35.91%

Industry -35.91%

Asset Turnover

1.34

Sector 0.02

Industry 0.02

Profitability

ROE

Sector -56.67%

Industry -56.67%

ROA

Sector -59.91%

Industry -59.91%

ROIC

1,645.06%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

17.66

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-0.81

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-0.81

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.03

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.94

Sector 0.46

Industry 0.46

Liabilities/Assets

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals IGMS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IGMS IGM Biosciences Inc.	$0.00	-	0.00%	0.00	0.00	0.00%	0.00%
JNJ Johnson & Johnson	$271.93	57.84%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.65	23.17%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$264.76	22.81%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$39.68	-32.15%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$149.06	90.05%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$167.85	11.92%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.04	48.15%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.34	-50.16%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$392.19	41.20%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$793.57	34.58%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.35	44.39%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$887.18	27.70%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$513.09	33.92%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.92	52.94%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$996.86	35.30%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$41.98	29.01%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IGMS Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IGM Biosciences

IGM Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

33 years

Founded: 1993

2019

Time since IPO - 7 years

107

Employees

IGM Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $100.93 million.

The company employs approximately 107 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, IGM Biosciences Inc. reported $288.15 million in revenue, generating net income of $105.62 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker IGMS.

Market cap

Net worth

$100.93 million

$100,930,000.00

Assets

$106.99 million

$106,990,000.00

Total Shares Outstanding

61.00 million

61,000,000

Average Daily Trading Volume

$708.48 Thousand

$708,479.06

Sector

Health Care

Industry

Biotechnology

IGMS

IGMS revenue and profits

Financial Results IGMS

DRAG THE FRAME TO SEE MORE DATA

IGMS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$887.18 27,70% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.92 52,94% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$271.93 57,84% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$264.76 22,81% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$149.06 90,05% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$167.85 10,16% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.65 23,17% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$887.18 27,70% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.92 52,94% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$271.93 57,84% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$264.76 22,81% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$149.06 90,05% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$167.85 10,16% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.65 23,17% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of IGM Biosciences (IGMS) today?

A cotação de IGM Biosciences (IGMS) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de IGM Biosciences (IGMS) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de IGM Biosciences (IGMS) e dados de ações do Ibovespa e mercados internacionais.

Quando IGM Biosciences (IGMS) paga dividendos?

IGM Biosciences (IGMS) não distribuiu dividendos no último ano.

Is IGM Biosciences (IGMS) a good investment?

Atualmente, IGM Biosciences (IGMS) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de -%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy IGM Biosciences (IGMS) stock?

Investir em ações de IGM Biosciences (IGMS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of IGM Biosciences (IGMS) yield today?

A rentabilidade de IGM Biosciences (IGMS) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de -%.

Se você quisesse comprar 100 ações de IGM Biosciences (IGMS) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IGMS

IGM Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IGMS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IGMS WITH OTHER STOCK

current DY: %

5-year average DY: 0.00%

ABOUT IGM Biosciences

IGM Biosciences Inc.

United States

33 years

2019

107

PROFIT X PRICE IGMS

Financial Results IGMS

IGMS cash flow

Asset, Revenue and Profit Growth - IGMS

IGMS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions